688046 药康生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资69,091-0.15%69,19868,53630,0770
投资性房地产7,972--0000
固定资产495,6171.83%486,699194,079175,959159,540
在建工程89,8470.27%89,603171,67053,0152,899
无形资产46,927-0.87%47,34148,51449,53541,199
商誉0--0000
其他非流动资产160,623-29.31%227,226303,90738,89832,309
870,079-5.43%920,067786,706347,483235,946

流动资产
货币资金770,43537.54%560,166421,708293,517524,172
应收账款358,48333.07%269,390185,216118,57190,678
存货53,55413.72%47,09249,47130,08417,322
其他流动资产561,636-28.08%780,875810,616264,75415,075
1,744,1085.22%1,657,5231,467,010706,926647,247

流动负债
短期借款108,10941.96%76,15712,2065,1535,018
应付票据0--0005,000
应付帐款94,588-7.14%101,86050,78761,73041,308
其他流动负债223,94718.87%188,392151,077124,85298,139
426,64416.44%366,409214,070191,735149,465
流动资产净值1,317,4652.04%1,291,1141,252,940515,191497,782
资产总额减流动负债2,187,543-1.07%2,211,1812,039,647862,674733,728

非流动负债
长期借款0--0020,0270
应付债券0--0000
其他非流动负债74,343-14.08%86,52461,93357,01476,485
74,343-14.08%86,52461,93377,04176,485

总权益
    实收股本410,0000.00%410,000410,000360,000360,000
    储备项目1,703,200-0.67%1,714,6561,567,714425,633297,244
股东权益2,113,200-0.54%2,124,6561,977,714785,633657,244
非控股权益0--0000